Prevalence of SARS-CoV-2 Antibodies Among Healthy Children From Colorado From 2020 to 2021: A Brief Report

There are few estimates of the seroprevalence of SARS-CoV-2 antibodies among children in the United States. We measured vaccine and infection induced seroprevalence among nearly 5000 healthy 1 to 17-year-old children in Colorado from 2020 to 2021. By December 2021, 89% of older children, ages 12 to...

Descripción completa

Detalles Bibliográficos
Autores principales: Frost, Holly M., Geno Rasmussen, Cristy, Shorrosh, Hanan, Pyle, Laura, Bautista, Kimberly, Frohnert, Brigitte I., Stahl, Marisa, Simmons, Kimber, Steck, Andrea K., Jia, Xiaofan, Yu, Liping, Rewers, Marian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Case Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375226/
https://www.ncbi.nlm.nih.gov/pubmed/37501515
http://dx.doi.org/10.1177/21501319231189147
_version_ 1785078992049537024
author Frost, Holly M.
Geno Rasmussen, Cristy
Shorrosh, Hanan
Pyle, Laura
Bautista, Kimberly
Frohnert, Brigitte I.
Stahl, Marisa
Simmons, Kimber
Steck, Andrea K.
Jia, Xiaofan
Yu, Liping
Rewers, Marian
author_facet Frost, Holly M.
Geno Rasmussen, Cristy
Shorrosh, Hanan
Pyle, Laura
Bautista, Kimberly
Frohnert, Brigitte I.
Stahl, Marisa
Simmons, Kimber
Steck, Andrea K.
Jia, Xiaofan
Yu, Liping
Rewers, Marian
author_sort Frost, Holly M.
collection PubMed
description There are few estimates of the seroprevalence of SARS-CoV-2 antibodies among children in the United States. We measured vaccine and infection induced seroprevalence among nearly 5000 healthy 1 to 17-year-old children in Colorado from 2020 to 2021. By December 2021, 89% of older children, ages 12 to 18, had antibodies detected. The increase was largely driven from vaccination rather than infection.
format Online
Article
Text
id pubmed-10375226
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-103752262023-07-28 Prevalence of SARS-CoV-2 Antibodies Among Healthy Children From Colorado From 2020 to 2021: A Brief Report Frost, Holly M. Geno Rasmussen, Cristy Shorrosh, Hanan Pyle, Laura Bautista, Kimberly Frohnert, Brigitte I. Stahl, Marisa Simmons, Kimber Steck, Andrea K. Jia, Xiaofan Yu, Liping Rewers, Marian J Prim Care Community Health Case Studies There are few estimates of the seroprevalence of SARS-CoV-2 antibodies among children in the United States. We measured vaccine and infection induced seroprevalence among nearly 5000 healthy 1 to 17-year-old children in Colorado from 2020 to 2021. By December 2021, 89% of older children, ages 12 to 18, had antibodies detected. The increase was largely driven from vaccination rather than infection. SAGE Publications 2023-07-27 /pmc/articles/PMC10375226/ /pubmed/37501515 http://dx.doi.org/10.1177/21501319231189147 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Case Studies
Frost, Holly M.
Geno Rasmussen, Cristy
Shorrosh, Hanan
Pyle, Laura
Bautista, Kimberly
Frohnert, Brigitte I.
Stahl, Marisa
Simmons, Kimber
Steck, Andrea K.
Jia, Xiaofan
Yu, Liping
Rewers, Marian
Prevalence of SARS-CoV-2 Antibodies Among Healthy Children From Colorado From 2020 to 2021: A Brief Report
title Prevalence of SARS-CoV-2 Antibodies Among Healthy Children From Colorado From 2020 to 2021: A Brief Report
title_full Prevalence of SARS-CoV-2 Antibodies Among Healthy Children From Colorado From 2020 to 2021: A Brief Report
title_fullStr Prevalence of SARS-CoV-2 Antibodies Among Healthy Children From Colorado From 2020 to 2021: A Brief Report
title_full_unstemmed Prevalence of SARS-CoV-2 Antibodies Among Healthy Children From Colorado From 2020 to 2021: A Brief Report
title_short Prevalence of SARS-CoV-2 Antibodies Among Healthy Children From Colorado From 2020 to 2021: A Brief Report
title_sort prevalence of sars-cov-2 antibodies among healthy children from colorado from 2020 to 2021: a brief report
topic Case Studies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375226/
https://www.ncbi.nlm.nih.gov/pubmed/37501515
http://dx.doi.org/10.1177/21501319231189147
work_keys_str_mv AT frosthollym prevalenceofsarscov2antibodiesamonghealthychildrenfromcoloradofrom2020to2021abriefreport
AT genorasmussencristy prevalenceofsarscov2antibodiesamonghealthychildrenfromcoloradofrom2020to2021abriefreport
AT shorroshhanan prevalenceofsarscov2antibodiesamonghealthychildrenfromcoloradofrom2020to2021abriefreport
AT pylelaura prevalenceofsarscov2antibodiesamonghealthychildrenfromcoloradofrom2020to2021abriefreport
AT bautistakimberly prevalenceofsarscov2antibodiesamonghealthychildrenfromcoloradofrom2020to2021abriefreport
AT frohnertbrigittei prevalenceofsarscov2antibodiesamonghealthychildrenfromcoloradofrom2020to2021abriefreport
AT stahlmarisa prevalenceofsarscov2antibodiesamonghealthychildrenfromcoloradofrom2020to2021abriefreport
AT simmonskimber prevalenceofsarscov2antibodiesamonghealthychildrenfromcoloradofrom2020to2021abriefreport
AT steckandreak prevalenceofsarscov2antibodiesamonghealthychildrenfromcoloradofrom2020to2021abriefreport
AT jiaxiaofan prevalenceofsarscov2antibodiesamonghealthychildrenfromcoloradofrom2020to2021abriefreport
AT yuliping prevalenceofsarscov2antibodiesamonghealthychildrenfromcoloradofrom2020to2021abriefreport
AT rewersmarian prevalenceofsarscov2antibodiesamonghealthychildrenfromcoloradofrom2020to2021abriefreport

Ejemplares similares